Shin Nippon Biomedical Laboratories, Ltd.

  • Market Cap: Small Cap
  • Industry: Miscellaneous
  • ISIN: JP3379950003
JPY
1,455.00
9 (0.62%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
6,429.09
8,289.11
6,477.68
10,178.44
9,726.89
6,958.96
5,549.52
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
6,429.09
8,289.11
6,477.68
10,178.44
9,726.89
6,958.96
5,549.52
Raw Material Cost
2,198.19
4,680.62
3,408.39
4,900.75
4,566.97
3,460.36
2,524.78
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
78.15
68.64
57.82
54.54
54.21
53.44
40.55
Selling and Distribution Expenses
1,765.30
2,665.24
2,680.22
3,797.74
2,792.99
2,614.38
2,552.94
Other Expenses
140.88
48.44
67.22
33.41
49.88
60.56
57.64
Total Expenditure (Excl Depreciation)
5,450.49
7,898.86
6,818.61
9,087.17
7,912.97
6,733.74
5,694.71
Operating Profit (PBDIT) excl Other Income
978.6
390.20000000000005
-340.90000000000003
1091.3
1813.8999999999999
225.2
-145.2
Other Income
525.74
673.25
738.47
1,163.91
517.77
1,281.93
497.95
Operating Profit (PBDIT)
2,383.59
1,879.14
1,142.02
3,010.60
3,050.71
2,132.71
863.86
Interest
78.15
68.64
57.82
54.54
54.21
53.44
40.55
Exceptional Items
0.00
-4.57
-6.22
-216.60
-4.41
-8.81
-1.11
Gross Profit (PBDT)
4,230.89
3,608.49
3,069.29
5,277.69
5,159.92
3,498.59
3,024.75
Depreciation
879.26
815.64
744.48
755.42
719.01
625.56
511.09
Profit Before Tax
1,426.18
990.29
333.50
1,984.03
2,273.07
1,444.90
311.09
Tax
229.77
209.00
77.00
295.57
409.49
246.77
196.68
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,209.69
800.70
260.42
1,719.30
1,874.51
1,208.84
122.19
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,209.69
800.70
260.42
1,719.30
1,874.51
1,208.84
122.19
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-13.28
-19.41
-3.92
-30.84
-10.93
-10.71
-7.79
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,196.41
781.29
256.50
1,688.46
1,863.58
1,198.14
114.41
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
52,858.58
37,874.26
35,513.48
40,022.74
44,988.21
36,429.23
33,319.07
Earnings per share (EPS)
29.06
19.23
6.26
41.3
45.03
29.04
2.94
Diluted Earnings per share
29.06
19.23
6.26
41.3
45.03
29.04
2.94
Operating Profit Margin (Excl OI)
15.22%
4.71%
-5.26%
10.72%
18.65%
3.24%
-2.62%
Gross Profit Margin
35.86%
21.79%
16.64%
26.91%
30.76%
29.75%
14.82%
PAT Margin
18.82%
9.66%
4.02%
16.89%
19.27%
17.37%
2.2%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is -33.90% vs 59.44% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is -35.80% vs 124.18% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is -26.65% vs 290.64% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is 44.28% vs 58.48% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024

Compare Quarterly Results Of Shin Nippon Biomedical Laboratories, Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
6,429.09
30,899.00
-24,469.91
-79.19%
Other Operating Income
0.00
0.00
0.00
Total Operating income
6,429.09
30,899.00
-24,469.91
-79.19%
Raw Material Cost
2,198.19
22,466.00
-20,267.81
-90.22%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
78.15
4.00
74.15
1,853.75%
Selling and Distribution Expenses
1,765.30
4,977.00
-3,211.70
-64.53%
Other Expenses
140.88
-0.40
141.28
35,320.00%
Total Expenditure (Excl Depreciation)
5,450.49
27,443.00
-21,992.51
-80.14%
Operating Profit (PBDIT) excl Other Income
978.59
3,456.00
-2,477.41
-71.68%
Other Income
525.74
842.00
-316.26
-37.56%
Operating Profit (PBDIT)
2,383.59
5,178.00
-2,794.41
-53.97%
Interest
78.15
4.00
74.15
1,853.75%
Exceptional Items
0.00
-2.00
2.00
100.00%
Gross Profit (PBDT)
4,230.89
8,433.00
-4,202.11
-49.83%
Depreciation
879.26
880.00
-0.74
-0.08%
Profit Before Tax
1,426.18
4,289.00
-2,862.82
-66.75%
Tax
229.77
1,378.00
-1,148.23
-83.33%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,209.69
2,634.00
-1,424.31
-54.07%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,209.69
2,634.00
-1,424.31
-54.07%
Share in Profit of Associates
0
0
0.00
Minority Interest
-13.28
276.00
-289.28
-104.81%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,196.41
2,910.00
-1,713.59
-58.89%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
52,858.58
73,323.00
-20,464.42
-27.91%
Earnings per share (EPS)
29.06
167.23
-138.17
-82.62%
Diluted Earnings per share
29.06
167.23
-138.17
-82.62%
Operating Profit Margin (Excl OI)
15.22%
11.18%
0.00
4.04%
Gross Profit Margin
35.86%
16.73%
0.00
19.13%
PAT Margin
18.82%
8.52%
0.00
10.30%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 642.91 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -22.44% vs 27.96% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -33.90% vs 59.44% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 119.64 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 53.13% vs 204.60% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -35.80% vs 124.18% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 185.79 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 54.07% vs 198.86% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -26.65% vs 290.64% in Dec 2024

Quarterly - Interest
Interest 7.82 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 13.99% vs 18.69% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 44.28% vs 58.48% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.22%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024